Market Overview

Earnings Scheduled For March 7, 2013

Share:
Earnings Scheduled For March 7, 2013

The Kroger Co (NYSE: KR) is estimated to report its Q4 earnings at $0.70 per share on revenue of $24.01 billion.

FLY Leasing (NYSE: FLY) is expected to report its Q4 earnings at $0.74 per share on revenue of $105.36 million.

Smithfield Foods (NYSE: SFD) is estimated to report its Q3 earnings at $0.51 per share on revenue of $3.53 billion.

Ciena (NASDAQ: CIEN) is projected to post a Q1 loss at $0.13 per share on revenue of $448.27 million.

Navistar International (NYSE: NAV) is expected to post a Q1 loss at $1.73 per share on revenue of $2.81 billion.

Blount International (NYSE: BLT) is estimated to report its Q4 earnings at $0.23 per share on revenue of $231.90 million.

Ferrellgas Partners LP (NYSE: FGP) is expected to report its Q2 earnings at $0.82 per share on revenue of $625.03 million.

The Descartes Systems Group (NASDAQ: DSGX) is projected to report its Q4 earnings at $0.15 per share on revenue of $33.45 million.

Hi Tech Pharmacal Co (NASDAQ: HITK) is expected to report its Q3 earnings at $0.71 per share on revenue of $60.45 million.

H&R Block (NYSE: HRB) is estimated to post a Q3 loss at $0.01 per share on revenue of $563.60 million.

Workday (NYSE: WDAY) is expected to post a Q4 loss at $0.20 per share on revenue of $78.24 million.

Westport Innovations (NASDAQ: WPRT) is projected to post a Q4 loss at $0.45 per share on revenue of $75.90 million.

Finisar (NASDAQ: FNSR) is expected to post its Q3 earnings at $0.16 per share on revenue of $238.36 million.

Nexstar Broadcasting Group (NASDAQ: NXST) is estimated to report its Q4 earnings at $0.56 per share on revenue of $115.39 million.

IDT (NYSE: IDT) is projected to post its Q2 earnings at $0.30 per share on revenue of $406.50 million.

WuXi PharmaTech (Cayman) (NYSE: WX) is expected to post its Q4 earnings at $0.30 per share on revenue of $123.71 million.

Medifast (NYSE: MED) is estimated to post its Q4 earnings at $0.25 per share on revenue of $82.90 million.

Chesapeake Utilities (NYSE: CPK) is expected to post its Q4 earnings at $0.87 per share on revenue of $108.80 million.

Thor Industries (NYSE: THO) is projected to post its Q2 earnings at $0.38 per share on revenue of $715.73 million.

Pandora Media (NYSE: P) is estimated to post a Q4 loss at $0.05 per share on revenue of $122.81 million.

US Physical Therapy (NASDAQ: USPH) is projected to report its Q4 earnings at $0.33 sp on revenue of $61.99 million.

Skullcandy (NASDAQ: SKUL) is estimated to post its Q4 earnings at $0.48 per share on revenue of $98.61 million.

Main Street Capital (NYSE: MAIN) is expected to post its Q4 earnings at $0.49 per share on revenue of $23.78 million.

Quiksilver (NYSE: ZQK) is projected to post a Q1 loss at $0.07 per share on revenue of $465.00 million.

Ambarella (NASDAQ: AMBA) is estimated to post its Q4 earnings at $0.13 per share on revenue of $29.20 million.

CECO Environmental (NASDAQ: CECE) is expected to report its Q4 earnings at $0.18 per share on revenue of $38.27 million.

Comtech Telecommunications (NASDAQ: CMTL) is projected to post its Q2 earnings at $0.11 per share on revenue of $77.12 million.

Sarepta Therapeutics (NASDAQ: SRPT) is estimated to post a Q4 loss at $0.29 per share on revenue of $6.71 million.

Quanex Building Products (NYSE: NX) is projected to post a Q1 loss at $0.07 per share on revenue of $175.08 million.

John Wiley & Sons (NYSE: JW-A) is estimated to report its Q3 earnings at $0.83 per share on revenue of $455.95 million.

James River Coal Co (NASDAQ: JRCC) is projected to post a Q4 loss at $1.41 per share on revenue of $244.63 million.

Repligen (NASDAQ: RGEN) is expected to report its Q1 earnings at $0.11 per share.

IFM Investments (NYSE: CTC) is estimated to report its Q4 earnings at $0.00 per share on revenue of $32.33 million.

LRR Energy LP (NYSE: LRE) is expected to report its Q4 earnings at $0.38 per share on revenue of $31.12 million.

Cantel Medical (NYSE: CMN) is projected to report its Q2 earnings at $0.35 per share.

Celldex Therapeutics (NASDAQ: CLDX) is estimated to post a Q4 loss at $0.25 per share on revenue of $2.45 million.

Posted-In: Earnings ScheduledEarnings News Pre-Market Outlook Markets

 

Related Articles (BLT + AMBA)

View Comments and Join the Discussion!

Standard Life Posts Higher Full-Year Profit, Announces Special Dividend

Top 4 Small-Cap Stocks In The Property Management Industry With The Highest Dividend Yield